1-6 of 6
Ahmad Zarzour, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incorporation of Molecular Data into the Current Prognostic Models in Treated Patients with Myelodysplastic Syndromes: Which Model Is the Best

Karam Al-Issa, MD, Ahmad Zarzour, MD, Tomas Radivoyevitch, PhD, Matt Kalaycio, MD, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Vera Adema, PhD, Michael J. Clemente, M.S., Bhumika Patel, MD, Cassandra M. Hirsch, BSc, Anjali S. Advani, MD, Bartlomiej P Przychodzen, MSc, Hetty E. Carraway, MD MBA, Jaroslaw P Maciejewski, MD PhD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD
Journal: Blood
Blood (2016) 128 (22): 50.
https://doi.org/10.1182/blood.V128.22.50.50
Published: 2016
Journal Articles

Outcome of Newly Diagnosed Acute Myeloid Leukemia (AML) Refractory to 1 or 2 Cycles of Induction Chemotherapy

Ahmad Zarzour, MD, Aziz Nazha, MD, Matt Kalaycio, MD, Bhumika J. Patel, Aaron T. Gerds, MD MS, Michael J. Clemente, Cassandra M Hirsch, Jennifer S. Carew, PhD, Anjali S. Advani, MD, Srinivasa R. Sanikommu, MBBS, Bartlomiej Przychodzen, MSc, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MD PhD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2015) 126 (23): 1319.
https://doi.org/10.1182/blood.V126.23.1319.1319
Published: 2015
Journal Articles

The Complexity of Interpreting Genomic Data in Patients with Primary and Secondary Acute Myeloid Leukemia (AML)

Aziz Nazha, MD, Ahmad Zarzour, MD, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Jennifer S. Carew, PhD, Cassandra M Hirsch, Kassy E Kneen, Bartlomiej Przychodzen, MSc, Bhumika J. Patel, Michael Clemente, MS, Srinivasa R. Sanikommu, MBBS, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2015) 126 (23): 86.
https://doi.org/10.1182/blood.V126.23.86.86
Published: 2015
Journal Articles

Impact of Non- JAK2 Molecular Mutations and Cryptic SNP Lesions in Myelofibrosis Patients Treated with Ruxolitinib

Jing Ai, MD PhD, Valeria Visconte, PhD, Ali Tabarroki, MD, Ahmad Zarzour, MD, Christopher Gerace, Karam Al-Issa, MD, Evan Hsi, Yasmine Hirbawi, Betty K. Hamilton, MD, Eric D. Hsi, MD, Heesun J. Rogers, MD PhD, Ramon V. Tiu, MD
Journal: Blood
Blood (2014) 124 (21): 3194.
https://doi.org/10.1182/blood.V124.21.3194.3194
Published: 2014
Journal Articles

Burden of Disease and Clinical Responses in Low and Intermediate-1 Risk Myelofibrosis Patients Treated with Ruxolitinib

Ahmad Zarzour, MD, Ali Tabarroki, MD, Valeria Visconte, PhD, Rokana Taftaf, MD, Heesun J. Rogers, MD PhD, Jing Ai, MD PhD, Nikolaos Papadantonakis, MD PhD, Alan E. Lichtin, Yogen Saunthararajah, MD, Brady L Stein, MDMHS, Ramon V. Tiu, MD
Journal: Blood
Blood (2014) 124 (21): 1834.
https://doi.org/10.1182/blood.V124.21.1834.1834
Published: 2014
Journal Articles

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

Ahmad Zarzour, MD, Ali Tabarroki, MD, Rokana Taftaf, MD, Valeria Visconte, PhD, Jing Ai, MD PhD, Betty K. Hamilton, MD, Nikolaos Papadantonakis, MD PhD, Alan E. Lichtin, Leonard J. Horwitz, MD, Anjali S. Advani, MD, Mikkael A. Sekeres, MD MS, Ramon V. Tiu, MD
Journal: Blood
Blood (2014) 124 (21): 1835.
https://doi.org/10.1182/blood.V124.21.1835.1835
Published: 2014